[Cytogenetics of acute and chronic leukemia and other malignant diseases]

A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features.

Leukemia·1992

A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

The EMBO journal·1992

Relapse as acute monoblastic leukemia (AML-M5) of t(6;9) acute myeloblastic leukemia (AML-M2).

Leukemia·1992

Tumor-associated karyotypic lesions coselected with in vitro macrophage differentiation.

Genes, chromosomes & cancer·1992

Abnormalities of chromosome 18 in myelodysplastic syndromes and secondary leukemia.

Cancer genetics and cytogenetics·1992

Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate.

Journal of cardiovascular pharmacology·1992

[Preparation of human albumin preparations].

Bilten za hematologiju i transfuziju·1984

[Problems and dilemmas in the testing of genetic characteristics of the blood for the purpose of determining disputed paternity (forensic hemogenetics)].

Bilten za hematologiju i transfuziju·1984

[Factor XII deficiency].

Bilten za hematologiju i transfuziju·1984

[Maternal-fetal alloimmunization in the Gm and InV system (inverse type of immunization in pregnancy)].

Bilten za hematologiju i transfuziju·1984

[Blood donation in Serbia, levels achieved, requirements and possibilities].

Bilten za hematologiju i transfuziju·1984

[Blood groups A and O with a weaker serological reactivity to agglutinins in the serum].

Bilten za hematologiju i transfuziju·1984

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Frontiers in medicine·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Current vascular pharmacology·2026

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

The American journal of surgical pathology·2026

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Virus genes·2026

Related Experiment Videos

[Cytogenetics of acute and chronic leukemia and other malignant diseases]

Related Concept Videos

A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features.

A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

Relapse as acute monoblastic leukemia (AML-M5) of t(6;9) acute myeloblastic leukemia (AML-M2).

Tumor-associated karyotypic lesions coselected with in vitro macrophage differentiation.

Abnormalities of chromosome 18 in myelodysplastic syndromes and secondary leukemia.

Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate.

[Preparation of human albumin preparations].

[Problems and dilemmas in the testing of genetic characteristics of the blood for the purpose of determining disputed paternity (forensic hemogenetics)].

[Factor XII deficiency].

[Maternal-fetal alloimmunization in the Gm and InV system (inverse type of immunization in pregnancy)].

[Blood donation in Serbia, levels achieved, requirements and possibilities].

[Blood groups A and O with a weaker serological reactivity to agglutinins in the serum].

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Related Experiment Videos

[Cytogenetics of acute and chronic leukemia and other malignant diseases]

Related Concept Videos

Related Articles